Veterinary Research Communications

, Volume 30, Supplement 1, pp 269–272 | Cite as

In Vitro Evaluation of Antiviral Activity of Ribavirin Against Canine Distemper Virus

  • A. Scagliarini
  • F. Vaccari
  • L. Gallina
  • F. Dal Pozzo
  • S. Prosperi
Article

Keywords

canine distemper virus cytototoxic concentration 50 inhibitory concentration 50 ribavirin 

Abbreviations:

CDV

Canine Distemper Virus

CC50

cytototoxic concentration 50

IC50

inhibitory concentration 50

RBV

ribavirin

SI

selectivity index

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barrett, T., Visser, I.K., Mamaev, L., Goatley, L., van Bressem, M.F. and Osterhaust, A.D., 1993. Dolphin and porpoise morbilliviruses are genetically distinct from phocine distemper virus. Virology, 193, 1010–1012PubMedCrossRefGoogle Scholar
  2. Crance, J.M., Scaramozzino, N., Jouan, A. and Garin, D., 2003. Interferon, ribavirin., 6- azauridine and glycyrrhizin: Antiviral compounds active against pathogenic flaviviruses. Antiviral Research, 58, 73–79PubMedCrossRefGoogle Scholar
  3. Denizot, F. and Lang, R., 1986. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods, 89, 271–277PubMedCrossRefGoogle Scholar
  4. Forni, A.L., Schluger, N.W. and Roberts, R.B., 1994. Severe measles pneumonitis in adults: Evaluation of clinical characteristics and therapy with intravenous ribavirin. Clinic of Infectious Diseases, 19, 454–462Google Scholar
  5. Garcia, S., Crance, J.M., Billecocq, A., Peinnequin, A., Jouan, A., Bouloy, M. and Garin, D., 2001. Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds. Journal of Clinical Microbiology, 39, 4456–4461PubMedCrossRefGoogle Scholar
  6. Hara, S., Kimura, H., Hoshino, Y., Hayashi, N., Negoro, T., Okumura, A., Kajita, Y., Sakuma, T., Nakayama, T., Hosoya, M., Tomoda, A. and Morisima, T., 2003. Combination therapy with intraventricular interferon-alpha and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay. Brain Development, 25, 367–369PubMedCrossRefGoogle Scholar
  7. Hosoya, M., Mori, S., Tomoda, A., Mori, K., Sawaishi, Y., Kimura, H., Shigeta, S. and Suzuki, H., 2004. Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis. Antimicrobial Agents Chemotherapy, 48, 4631–4635CrossRefGoogle Scholar
  8. Hussain, R.F., Nouri, A.M. and Oliver, R.T., 1993. A new approach for measurement of cytotoxicity using colorimetric assay. Journal of Immunological Methods, 160, 89–96PubMedCrossRefGoogle Scholar
  9. Poynard, T., Marcellin, P., Lee, S.S., Niederau, C., Minuk, G.S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C. and Albrecht, J., 1998. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lance, 352, 1426–1432CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • A. Scagliarini
    • 1
  • F. Vaccari
    • 1
  • L. Gallina
    • 1
  • F. Dal Pozzo
    • 1
  • S. Prosperi
    • 1
  1. 1.Department of Veterinary Public Health and Animal Pathology, Facoltà di Medicina Veterinaria, Alma Mater StudiorumUniversità di BolognaItaly

Personalised recommendations